论文部分内容阅读
本文将对我院2013年12月至2014年12月期间收治的46例明确诊断的进展期胃癌患者的临床资料进行回顾性分析,观察应用新辅助化疗XELOX方案治疗进展期胃癌的临床疗效。1资料与方法1.1临床资料入组条件:行胃镜检查并取病理证实为胃窦腺癌;化疗前行腹部CT、超声内镜、胃镜、胸片、彩超、肿瘤标记物等检查后按照TNM分期标准确定分期ⅢA、ⅢB。
This article will retrospectively analyze the clinical data of 46 patients with advanced gastric cancer diagnosed from December 2013 to December 2014 in our hospital and observe the clinical efficacy of neoadjuvant chemotherapy XELOX regimen in the treatment of advanced gastric cancer. 1 Materials and Methods 1.1 Clinical data Inclusion conditions: gastroscopy and pathology confirmed as gastric adenocarcinoma; before chemotherapy, abdominal CT, ultrasound endoscopy, gastroscopy, chest radiograph, color Doppler ultrasound, tumor markers and other tests according to TNM staging Standard to determine the stage Ⅲ A, Ⅲ B.